EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Differential Outcomes of Early Versus Late Anti‐TNF Therapy in Ulcerative Colitis and Crohn's Disease: A Nationwide Propensity Score‐Matched Cohort Study

Shin Ju Oh iD, Min-Taek Lee, Ji Eun Kim, Chi Hyuk Oh, Sun-Young Jung, Chang Kyun Lee iD

United European Gastroenterology Journal · 2025

DOI: 10.1002/ueg2.70071 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Shin Ju Oh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Center for Crohn's and Colitis, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Tumor Necrosis Factor-alpha, Tumor Necrosis Factor Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health & Welfare, Republic of Korea, Korean Society of Gastroenterology, National Health Insurance Service in Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early advanced inflammatory bowel disease (IBD) therapy is emphasised to prevent disease progression and restore quality of life.

Aims

To evaluate the potential advantages of early versus late anti‐tumour necrosis factor (TNF) therapy in patients with IBD.

Methods

This retrospective study included patients with newly diagnosed IBD (2004–2018) who received anti‐TNF therapy and had at least 1 year of follow‐up. Patients were categorised as early or late users based on a 2‐year post‐diagnosis cut‐off for first anti‐TNF exposure. Outcomes included IBD‐related surgeries, hospitalizations, emergency department (ED) visits, and drug persistence. Subgroup analysis examined concurrent immunomodulator use, and sensitivity analyses were employed 6 months or 1 year post‐diagnosis cut‐offs.

Results

Among 8105 patients with ulcerative colitis (UC) and 8465 with Crohn's disease (CD), distinct outcomes emerged. Early anti‐TNF users with UC had significantly higher hospitalization (hazard ratio [HR] 1.34, 95% confidence interval [CI] 0.91–1.96) and ED visit rates (HR 1.30, 95% CI 1.16–1.46) compared with late users. In CD, early users showed a non‐significant trend toward fewer event rates. Drug persistence was longer among late users for both UC and CD. In UC, combining immunomodulators with early anti‐TNF increased hospitalization and ED visits but not in CD. Sensitivity analyses confirmed the primary findings.

Conclusions

While early anti‐TNF use was associated with differential outcomes in CD, the relationship between treatment timing and clinical course diverged in UC, challenging the assumption that early intervention is universally advantageous across IBD subtypes. These findings underscore the need for further research to identify patient subgroups that might benefit most from early intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCrohn DiseaseTumor Necrosis Factor-alphaTumor Necrosis Factor InhibitorsHumansFemaleMaleRetrospective StudiesAdultPropensity ScoreHospitalizationMiddle AgedTreatment OutcomeEmergency Service, HospitalDisease ProgressionTime-to-TreatmentTime FactorsQuality of LifeYoung Adult

Stichwörter der Autor:innen

Crohn's diseaseanti‐TNFearly treatmenthospitalizationimmunomodulatorsinflammatory bowel diseaseoutcomestimingulcerative colitisvisits

Substanzen

Tumor Necrosis Factor-alphaTumor Necrosis Factor Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Center for Crohn's and Colitis, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea.
  • Department of Global Innovative Drugs and College of Pharmacy, Chung-Ang University, Seoul, Korea.
  • The Big Data Research Group (BDRG) of the Korean Society of Gastroenterology, Seoul, Korea.

ORCID-Profile: Shin Ju Oh, Chang Kyun Lee

Förderung

  • Ministry of Health & Welfare, Republic of Korea
  • Korean Society of Gastroenterology
  • National Health Insurance Service in Korea

Zitieren

APA

Oh, S. J., Lee, M. T., Kim, J. E., Oh, C. H., Jung, S. Y., & Lee, C. K. (2025). Differential Outcomes of Early Versus Late Anti‐TNF Therapy in Ulcerative Colitis and Crohn's Disease: A Nationwide Propensity Score‐Matched Cohort Study. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70071

Vancouver

Oh SJ, Lee MT, Kim JE, Oh CH, Jung SY, Lee CK. Differential Outcomes of Early Versus Late Anti‐TNF Therapy in Ulcerative Colitis and Crohn's Disease: A Nationwide Propensity Score‐Matched Cohort Study. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70071

BibTeX
@article{Oh2025,
  author = {Oh, Shin Ju and Lee, Min-Taek and Kim, Ji Eun and Oh, Chi Hyuk and Jung, Sun-Young and Lee, Chang Kyun},
  title = {Differential Outcomes of Early Versus Late Anti‐TNF Therapy in Ulcerative Colitis and Crohn's Disease: A Nationwide Propensity Score‐Matched Cohort Study},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  doi = {10.1002/ueg2.70071}
}
Kostenlos starten →